Left-sided Aspergillus fumigatus endocarditis was established in the guinea pig heart by
catheterization and inoculation with conidia via a tributary of the femoral vein. This animal …

The efficacy of amphotericin B, 5-fluorocytosine and itraconazole was compared for the
treatment of experimental rabbit Aspergillus fumigatus endocarditis. Therapy with …

Aspergillus endocarditis is very difficult to cure, even with aggressive surgical debridement
and antifungal therapy. Patients with embolic involvement of the central nervous system …

Voriconazole, a new azole antifungal agent, showed potent activity against clinical isolates
of Aspergillus spp. in vitro. For A. fumigatus, the MIC range was< 0.03 to 0.5 microgram/ml …

Voriconazole was compared with amphotericin B and itraconazole by a modification of the
NCCLS microdilution reference method for yeasts against 62 clinical isolates of Aspergillus …

Aspergillus endocarditis is a rare event after heart transplantation. We report a case of
Aspergillus fumigatus endocarditis after orthotopic heart transplantation. The patient was …

Voriconazole (VRC) was evaluated in an immunosuppressed-guinea pig model of invasive
aspergillosis. VRC was more effective than amphotericin B or similar doses of itraconazole …

We compared the Etest with a broth microdilution method, performed according to a
modified National Committee for Clinical Laboratory Standards guideline (M38-A), for …

Aspergillus endocarditis is a rare infection that may affect immunocompetent patients
following heart valve replacement or heart surgery. We report the case of a 39 year old …

The in-vitro activity of amphotericin B, itraconazole and voriconazole against 130 clinical
and 20 environmental Aspergillus fumigatus isolates was tested with an agar dilution …